Stuart McCracken Selected Research

Prostate-Specific Antigen (Semenogelase)

1/2023

Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stuart McCracken Research Topics

Disease

11	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 07/2005
6	Neoplasms (Cancer) 01/2023 - 01/2018
5	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2019
1	Hyperplasia 01/2018

Drug/Important Bio-Agent (IBA)

2	AndrogensIBA 01/2023 - 01/2021
2	Hormones (Hormone)IBA 01/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2005
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 08/2012
1	tyrosine receptor (receptor, tyrosine)IBA 08/2012

Therapy/Procedure

8	Therapeutics 01/2023 - 01/2019
5	Radiotherapy 01/2023 - 01/2021
4	Cryotherapy (Therapy, Cold) 01/2023 - 01/2019
3	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Neoadjuvant Therapy 01/2020